Prevalence and Determinants of End of Life Chemotherapy Use in Patients with Metastatic Breast Cancer

BACKGROUND: Cessation of chemotherapy in the last few weeks of life could be an important quality of care benchmark. Proportion of metastatic breast cancer patients who receive end of life chemotherapy is not well described. We aimed to determine the prevalence and determinants of end of life chemot...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Breast J
Huvudupphovsmän: Mathew, Aju, Achkar, Tala, Abberbock, Shira, Sandhu, Gurprataap S., Jacob, Mini Elizabeth, Das Villgran, Vipin, Rosenzweig, Margaret Q., Puhalla, Shannon, Brufsky, Adam M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5675818/
https://ncbi.nlm.nih.gov/pubmed/28845536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tbj.12905
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk